Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 40Neoplasms 5Colorectal Neoplasms 5Neoplasm Metastasis 3Resectable Pancreatic Cancer 2Rectal Neoplasms 2Carcinoma, Hepatocellular 2Adenocarcinoma 2Urachal cancer 1Stomach Neoplasms 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Pancreatic Cancer Metastatic 1Pancreatic Adenocarcinoma 1Neoplasms, Basal Cell 1Locally Advanced Pancreatic Adenocarcinoma 1Localized Pancreatic Adenocarcinoma 1Gastrointestinal Neoplasms 1Gastroesophageal Adenocarcinoma 1Gastro-enteropancreatic neuroendocrine tumor 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Pancreatic Ductal 1Carcinoma, Islet Cell 1Borderline Resectable Pancreatic Cancer 1Biliary Tract Neoplasms 1Ampullary Adenocarcinoma 1

Interventions

folfirinox 1Nivolumab 1Leucovorin 1Gemcitabine 1Fluorouracil 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Urachal cancer × folfirinox × Clear all
NCT04611724 2020-11-02

A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer

Asan Medical Center

Phase 2 Unknown
35 enrolled

Urachal cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡